Nexien BioPharma Inc NXEN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.03
- 52-Week Range
- $0.01–0.10
- Bid/Ask
- $0.02 / $0.03
- Market Cap
- $1.88 Mil
- Volume/Avg
- 2,517 / 10,008
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nexien BioPharma Inc is a researcher and developer of cannabinoid-based pharmaceutical for various medical conditions and disorders, all under U.S. Food and Drug Administration development pathways.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.nexienbiopharma.com
Valuation
|
Metric
|
NXEN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NXEN
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −3.39 |
Quick Ratio
NXEN
Profitability
|
Metric
|
NXEN
|
|---|---|
Return on Assets (Normalized) | −672.20% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NXEN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rjynrnfsx | Zpdpb | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Cdrfvcbdg | Czwcgyf | $69.1 Bil | |
HLN
| Haleon PLC ADR | Xdcqcqnq | Cnn | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ktzjhspw | Ychcp | $15.7 Bil | |
VTRS
| Viatris Inc | Nhpchvx | Zsds | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Dstbmkth | Lccs | $12.4 Bil | |
CTLT
| Catalent Inc | Blwympws | Wwmlb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mnplgtp | Qvvyx | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Lsblzyxq | Rnyj | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Srqjdxmt | Dhrscfc | $3.5 Bil |